Pharmacological treatment for dyslipidemia
Author:
Publisher
The Japanese Coronary Association
Link
https://www.jstage.jst.go.jp/article/jcoron/24/1/24_24.005/_pdf
Reference39 articles.
1. 1) Nakamura H, Arakawa K, Itakura H, et al; MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006; 368: 1155-1163
2. 2) Hosomi N, Nagai Y, Kohriyama T, et al; J-STARS Collaborators: The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, randomized, open-label, parallel-group study. EBioMedicine 2015; 2: 1071-1078
3. 3) Mizuno K, Nakaya N, Ohashi Y, et al; MEGA Study Group: Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study). Circulation 2008; 117: 494-502
4. 4) Uchiyama S, Nakaya N, Mizuno K, et al; MEGA Study Group: Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial. J Neurol Sci 2009; 284: 72-76
5. 5) Tanaka K, Ishikawa Y, Yokoyama M, et al; JELIS Investigators Japan: Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 2008; 39: 2052-2058
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3